Updated Results of a Phase 2 Study of Biweekly Dose-Intense Paclitaxel Plus Gemcitabine (GEM/TAX) in Patients With Recurrent Locoregional or Metastatic Head-and-Neck Squamous Cell Carcinoma

✍ Scribed by Salem, M.; Kaufman, M.; Shahrestani, S.; Al-Hajeili, M.; Jacobs, J.; Yoo, G.; Lin, H.; Smith, D.; Heilbrun, L.; Sukari, A.

• Book ID: 122867533
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 54 KB
• Volume: 88
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2013.11.137